Evidence map›Paper›PMID 32019777›Full record

ArticleBJGP open2020

Potentially inappropriate medications in older patients based on Beers criteria: a cross-sectional study of a family medicine practice in Saudi Arabia.

Atheer Alturki, Tareef Alaama, Yousef Alomran, Ahmed Al-Jedai, Hajer Almudaiheem, Ghassan Watfa

Open access · goldAbstract read
In one paragraph

Article in BJGP open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Use of potentially inappropriate medication for elderly patients in tertiary care hospital of Riyadh, Saudi Arabia.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 4 countries.

Atheer AlturkiFamily Medicine Specialist, King Saud Medical City, Central Health Cluster One, Riyadh, Kingdom of Saudi Arabia.
Tareef AlaamaDeputy Minister for Therapeutic Affairs, Ministry of Health, Deputyship of Therapeutic Affairs, Riyadh, Kingdom of Saudi Arabia.
Yousef AlomranConsultant of Family Medicine and Associate Executive Director for Primary Care and Community Health, King Saud Medical City, Central Health Cluster One, Riyadh, Kingdom of Saudi Arabia.
Ahmed Al-JedaiAssistant Deputy Minister for Medical Support Services, Ministry of Health, Deputyship of Therapeutic Affairs, Riyadh, Kingdom of Saudi Arabia.
Hajer AlmudaiheemDrug Policy Department Manager, Ministry of Health, Deputyship of Therapeutic Affairs, Riyadh, Kingdom of Saudi Arabia.
Ghassan WatfaConsultant of Geriatric Medicine and Director of Home Health Care Administration, King Saud Medical City, Central Health Cluster One, Riyadh, Kingdom of Saudi Arabia g.watfa@ksmc.med.sa.ORCID http://orcid.org/0000-0002-1559-6930
King Saud Medical City · SAAlfaisal University · SAKing Abdulaziz University · SAMinistry of Health of the Russian Federation · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe use of potentially inappropriate medications (PIMs) is an important issue in older patients who are at risk of adverse drug events.

aimTo determine the prevalence of PIM use, according to Beers criteria, among an older population (aged ≥65 years) in a large family medicine setting, and to identify the associated risks. DESIGN &

settingA prospective cross-sectional study of patients aged ≥65 years was conducted from June 2017 to June 2018 at the Family and Community Medicine (FCM) clinics of King Saud Medical City (KSMC) in Riyadh, Saudi Arabia.

methodThis cross-sectional study included patients aged ≥65 years who were seen at new appointments or followed-up at the FCM clinics of KSMC in Riyadh, Saudi Arabia. Data were collected by extensive face-to-face interviews and from the patients' medical records.

resultsA total of 270 older patients aged 72.41 ±6.23 years (mean ±standard deviation [SD]) were included in the present study. The prevalence of PIMs was 60.7% (

conclusionThis study showed high prevalence of PIMs. Increasing age, female sex, and polypharmacy were found to be significant risk factors for PIM use. The frequency of morbidities was not significantly different among patients with PIMs compared to those without PIMs, except for hypertension and osteoarthritis, which were more common in the PIMs group. The present study reinforces the importance of comprehensive medication management and reviews.

Indexed as

agedBeers criteriafamily medicinegeriatricspotentially inappropriate medicationsSaudi Arabia

Identifiers

PMID32019777
PMCPMC7330182
OpenAlexW3004472036

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.